Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) has provided an announcement.
Nanosonics Limited has reported an update to its on-market share buy-back program involving its ordinary fully paid shares listed under the ASX code NAN. The latest daily notification shows that the company had repurchased a cumulative 1,119,697 shares prior to the previous trading day, and acquired an additional 400,000 shares on the previous day as part of the ongoing buy-back.
The continued execution of the on-market buy-back signals active capital management, potentially supporting earnings per share and providing price support for existing shareholders. The company is regularly notifying the market of daily repurchase activity, underscoring transparency in how it is returning capital and managing its equity base over time.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australian-listed medical technology company trading under ASX code NAN, with ordinary fully paid shares on issue. The company operates in the healthcare sector and is best known for infection prevention solutions, with its shares actively traded on the Australian Securities Exchange.
Average Trading Volume: 464,792
Technical Sentiment Signal: Sell
Current Market Cap: A$1.03B
See more insights into NAN stock on TipRanks’ Stock Analysis page.